Novo Nordisk will maintain an attractive dividend per share; Novo Nordisk aims to serve more than 60 million patients globally by 2030; Novo Nordisk plans to maintain a generally stable operating margin; and Novo Nordisk targets pipeline product sales exceeding DKK 150 billion by 2035.

Novo Nordisk will maintain an attractive dividend per share; Novo Nordisk aims to serve more than 60 million patients globally by 2030; Novo Nordisk plans to maintain a generally stable operating margin; and Novo Nordisk targets pipeline product sales exceeding DKK 150 billion by 2035.